You are here

Article Text

Article menu
Download PDFPDF
Extended report
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis
  1. T Yli-Kerttulaa,
  2. R Luukkainend,
  3. U Yli-Kerttulae,
  4. T Möttönena,
  5. M Hakolaf,
  6. M Korpelae,
  7. M Sanilad,
  8. J Parviaineng,
  9. J Uksilab,
  10. R Vainionpääc,
  11. A Toivanena
  1. aDepartment of Medicine, Turku University, Finland, bDepartment of Medical Microbiology, Turku University, cDepartment of Virology, Turku University, dSatalinna Hospital, Finland, eDepartment of Medicine, Section of Rheumatology, Tampere University Hospital, Finland, fJyväskylä Central Hospital, Finland, gStat-X, Finland
  1. Dr Timo Yli-Kerttula, Department of Medicine, Turku University, Kiinamyllynkatu 4–8, FIN-20520 Turku, Finland Email: timo.yli-kerttula{at}utu.fi

Abstract

BACKGROUND Treatment of reactive arthritis (ReA) with antibiotics has so far remained controversial. Eradication of the causative microbe appears logical, but short term antibiotic treatment has no beneficial effect on the outcome of ReA.

OBJECTIVE To evaluate the effect of a three month course of ciprofloxacin on ReA.

METHODS In a randomised, double blind, placebo controlled trial, between December 1992 and February 1996, 71 patients with acute ReA triggered by a gastrointestinal or a urogenital infection were randomly assigned to receive ciprofloxacin 500 mg or placebo twice daily for three months. Patients were assessed at study entry, at 6 weeks, 3 months, 6 months, and 12 months. Sixty two patients were valid for the efficacy analysis. The primary outcome measures were erythrocyte sedimentation rate, number of swollen joints, patients self assessment, and complete recovery.

RESULTS Adverse events were mostly mild and occurred in both treatment groups. There were no statistically significant differences in any of the primary or secondary efficacy variables between the study groups at baseline or during the 12 month follow up. All primary outcome measures indicated that the condition of the patients improved during the study.

CONCLUSION Both groups tended to recover. Ciprofloxacin, given as a three month course, had no advantage over placebo treatment.

  • reactive arthritis
  • ciprofloxacin
  • outcome

https://doi.org/10.1136/ard.59.7.565

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text